• D. Boral Capital Reaffirms "Buy" Rating for ImmunityBio (NASDAQ:IBRX)

    المصدر: Buzz FX / 28 يناير 2025 03:40:18   America/New_York


    D. Boral Capital Reaffirms "Buy" Rating for ImmunityBio (NASDAQ:IBRX) Written by MarketBeat January 28, 2025 Share Link copied to clipboard. D. Boral Capital reissued their buy rating on shares of ImmunityBio ( NASDAQ:IBRX - Free Report ) i
    Read more...
شارك على،